Sirolimus-tacrolimus Combination Immunosuppression

Overview

Journal Lancet

Publisher Elsevier

Specialty General Medicine

Date 2000 Feb 9

PMID 10665560

Citations 36

Authors

V C McAlister

Z Gao

K Peltekian

J Domingues

K Mahalati

A S MacDonald

Affiliations

Soon will be listed here.

Abstract

A series of 32 recipients of liver, kidney, or pancreas transplants who were treated with sirolimus and low-dose tacrolimus experienced a low rate of rejection and excellent graft function without drug-related toxic effects.

Citing Articles

Long-term Outcomes With Islet-Alone and Islet-After-Kidney Transplantation for Type 1 Diabetes in the Clinical Islet Transplantation Consortium: The CIT-08 Study.

Rickels M, Eggerman T, Bayman L, Qidwai J, Alejandro R, Bridges N Diabetes Care. 2022; .

PMID: 36250905 PMC: 9767903. DOI: 10.2337/dc21-2688.

Comparison of LC-MS/MS and EMIT methods for the precise determination of blood sirolimus in children with vascular anomalies.

Zhao Y, Dai H, Li Y, Zhang Y, Guo H, Ding X Front Pharmacol. 2022; 13:925018.

PMID: 36147342 PMC: 9486013. DOI: 10.3389/fphar.2022.925018.

Incremental Concentrations of Tacrolimus Eye Drops as a Strategy for the Management of Severe Vernal Keratoconjunctivitis.

Albarry M, Parekh M, Ferrari S, Eltahir H, Shehata A, Shaker M Front Pharmacol. 2022; 13:798998.

PMID: 35401178 PMC: 8990096. DOI: 10.3389/fphar.2022.798998.

Treatment optimization of maintenance immunosuppressive agents in pediatric renal transplant recipients.

Job K, Roberts J, Enioutina E, Illamola S, Kumar S, Rashid J Expert Opin Drug Metab Toxicol. 2021; 17(7):747-765.

PMID: 34121566 PMC: 10726690. DOI: 10.1080/17425255.2021.1943356.

Tacrolimus promotes hepatocellular carcinoma and enhances CXCR4/SDF‑1α expression in vivo.

Zhu H, Sun Q, Tan C, Xu M, Dai Z, Wang Z Mol Med Rep. 2014; 10(2):585-92.

PMID: 24912495 PMC: 4094770. DOI: 10.3892/mmr.2014.2302.